HEALTH

• Medical researchers are warning that misinformation and vaccine hesitancy could limit the effectiveness of upcoming personalized cancer vaccines. • These vaccines are designed to prevent cancer from returning by training the immune system to recognize specific proteins on a patient's tumor. • Widespread distrust in vaccines may prevent high-risk patients from receiving preventative treatments that could stop a cancer recurrence.

• The FDA is meeting this Wednesday to gather input from the public and industry stakeholders for the next Prescription Drug User Fee Act, which will set agency priorities for fiscal years 2028–2032. • Health policy firm Aviva Strategies noted in a Friday memo that the FDA's Rare Disease Innovation Hub is working to align the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research. • This alignment aims to resolve a longstanding coordination issue for developers creating treatments for rare diseases.

• The FDA approved Scholar Rock's drug Isembyld for adults and children aged 2 and older who are already using therapies for spinal muscular atrophy (SMA). • A late-stage clinical trial showed that patients using Isembyld alongside an SMN2-targeting drug improved their motor skills after one year, while the placebo group declined. • This approval provides a new treatment option specifically targeting muscle loss for patients with SMA, a genetic condition affecting neurons that control movement.

• Moderna and Merck are developing an mRNA cancer vaccine to treat patients with late-stage skin cancer. • The vaccine showed success in clinical trials when used in combination with an immunotherapy drug. • Public distrust and disinformation regarding vaccines could limit the adoption and effectiveness of these new medical treatments.

• Clinical trials for the oral drug NV-387 will begin to treat a rapidly expanding outbreak of the Bundibugyo Ebolavirus in the Democratic Republic of the Congo. • The virus has spread into displacement camps hosting over 4.4 million people who lack adequate drinking water, sanitation, and medical resources. • This trial is critical because there is currently no approved treatment or vaccine for this specific variant of the Ebolavirus Disease.

• NanoViricides will begin a clinical trial next week for the oral drug NV-387 to treat an expanding Ebola outbreak in the Democratic Republic of Congo. • The current outbreak of the Bundibugyo Ebolavirus variant has a 48% crude fatality rate and no approved treatment or vaccine. • The virus has spread into displacement camps hosting over 4.4 million people, creating a high-risk population with poor sanitation and medical resources.

• Researchers at the Sylvester Comprehensive Cancer Center found that annual U.S. cancer deaths linked to alcohol consumption more than doubled between 1990 and 2023. • Data published in The Lancet Regional Health — Americas shows these deaths rose from 11,361 in 1990 to 23,126 in 2023. • A separate report from the Association for Accessible Medicines warns that 90% of expensive biologic drugs facing patent expiration by 2034 lack lower-cost alternatives in development.

• A new market for peptide-based medicines is emerging and growing quickly, building on a history of therapies that dates back to the 1920s. • Insulin served as one of the earliest and most important peptide therapies to help people manage diabetes. • The Food and Drug Administration has regulated and approved numerous peptide-based drugs since the 1940s.

• The White House signed secretive agreements with 26 drugmakers that may exempt various medicines from mandatory price reductions in Medicare. • A new analysis indicates these deals could drastically reduce the projected savings from the "most-favored nation" pricing policy, which aims to align U.S. drug costs with lower prices paid abroad. • These exemptions could limit the government's ability to lower prescription costs for millions of Medicare beneficiaries.

• The Centers for Disease Control and Prevention declared that the record-setting cyclosporiasis outbreak linked to iceberg lettuce has ended. • Health officials confirmed that all contaminated iceberg lettuce sourced from central Mexico and recalled by Taylor Farms de Mexico is now off the market. • Consumers no longer face a risk of getting sick from this specific batch of contaminated produce.

• The World Health Organization classified Candida albicans, C. auris, Aspergillus fumigatus, and Cryptococcus neoformans as critical priority fungi. • These specific fungi were selected based on their widespread prevalence and the high mortality rates associated with invasive mycoses, or deep-tissue fungal infections. • The classification highlights a growing global health risk as more fungal strains develop resistance to existing antifungal medications.

• A narrative review synthesized global data from 2000 to early 2026 to analyze the escalating crisis of antimicrobial resistance. • The study utilized surveillance data from the World Health Organization and Global Research on Antimicrobial Resistance to outline the scale of the problem. • This trend threatens to return medicine to a pre-antibiotic era where common infections become deadly for patients.

• The FDA approved a new treatment for pancreatic cancer to help patients fighting one of the deadliest forms of the disease. • Drug manufacturers may offer expanded access programs that allow patients who do not qualify for clinical trials to receive these newly approved therapies. • Patients and families can coordinate with oncologists at National Cancer Institute-designated facilities to identify which access programs are currently active.

• A new study released on September 10, 2026, found that statin therapy significantly reduces major heart-related events among older adults. • The research indicates that these medications lead to a 30% reduction in major cardiovascular events for this age group. • These findings suggest that older patients may lower their risk of heart attacks or strokes by utilizing statin treatments.

• The Department of War and the National Institutes of Health signed an interagency agreement to develop medical countermeasures against emerging infectious diseases and CBRN threats. • The partnership focuses on research and development for pandemic influenza and chemical, biological, radiological, and nuclear hazards. • This collaboration aims to strengthen the national ability to respond to large-scale health crises and weaponized biological or chemical attacks.

• The FDA approved six cancer drugs in August 2026, including a new pill for pancreatic cancer called Rasonque. • Patients taking Rasonque lived a median of 13.2 months compared to 6.7 months for those on chemotherapy, reducing the risk of death by roughly 60%. • This approval provides a significant survival increase for pancreatic cancer patients in a disease where gains are typically measured in weeks.

• Modern Healthcare is tracking the latest news on mergers, acquisitions, and joint partnerships in the healthcare industry. • The publication provides live updates on deals as they happen, giving readers insight into the changing healthcare landscape. • This coverage helps healthcare professionals and investors stay informed about potential opportunities and challenges in the market.

• The Indian Medical Association has requested intervention from Prime Minister Narendra Modi and the National Medical Commission regarding long working hours and harassment faced by doctors, which is causing severe burnout. • WHO Director-General Tedros Adhanom has praised India's progress in primary healthcare, maternal and child health, and non-communicable disease prevention and control, during a meeting with Union Health Minister J P Nadda. • The burnout among doctors and India's healthcare progress may impact the quality of medical care available to patients and the overall healthcare system in the country.